Enter Note Done
Go to previous page in this tab
Session
  • Presentation | Poster - [In-Person Posters Mon] Drug Development: Human
  • Poster
  • Design Of Applauds, A Phase 2 Study Of Mivelsiran In People With Down Syndrome And Early-stage Alzheimer’S Disease [Board No. Monday-0080]
  • Board no. Monday-0080
    Set Timezone

Michael S. Rafii1, Beau Ances2, Johannes Levin3, Sigan L. Hartley4, Bradley T. Christian4, Alexandre Sostelly5, Sasikiran Goteti5, Lan T. Dang5, Kirk Brown5, Robert Deering5, Julia Shirvan5, Juan Fortea6,7.
1Alzheimer’s Therapeutic Research Institute, Keck School of Medicine, University of Southern California, San Diego, CA, USA, 2Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA, 3Department of Neurology, LMU University Hospital, Munich, Germany, 4Waisman Center, University of Wisconsin-Madison, Madison, WI, USA, 5Alnylam Pharmaceuticals, Cambridge, MA, USA, 6Sant Pau Memory Unit, IR SANT PAU, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, 7Barcelona Down Medical Center,Fundació Catalana Síndrome de Down, Barcelona, Spain.
Types
Main Session